These results suggest that the pro-oncogenic properties of TAZ-AS202 are at least in part mediated by modulation of the protein level of the transcription factor E2F1 that in turn regulates the expression of EPHB2 and possibly other effectors, leading to increased cancer cells aggressiveness. This evidence concerns the gene E2F1 and cancer.